NEPH
Nephros Inc
NASDAQ: NEPH · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$3.17
-9.69% today
Updated 2026-10-28
Market cap
$38.34M
P/E ratio
23.53
P/S ratio
1.85x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$3 – $6
Volume
0.0M
Nephros Inc (NEPH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$3.17
12-Month target
$2.31
2030 Target
—
Intrinsic (DCF)
$4.58
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 23.53x (capped 25x) · Margin: 8.38%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.